Rapid Determination of Ractopamine Residues in Edible Animal Products by Enzyme-Linked Immunosorbent Assay: Development and Investigation of Matrix Effects by Zhang, Yan et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 579175, 9 pages
doi:10.1155/2009/579175
Research Article
RapidDeterminationof Ractopamine Residuesin
EdibleAnimalProducts by Enzyme-LinkedImmunosorbent
Assay: DevelopmentandInvestigation of Matrix Effects
YanZhang, FengXia Wang, Li Fang, Shuo Wang, andGuoZhenFang
Key Laboratory of Food Nutrition and Safety, Ministry of Education of China, Tianjin Key Laboratory of Food Nutrition and Safety,
Tianjin University of Science and Technology, Tianjin 300457, China
Correspondence should be addressed to Shuo Wang, s.wang2002@163.com
Received 20 February 2009; Revised 12 May 2009; Accepted 22 July 2009
Recommended by Harry W. Schroeder
To determine ractopamine residues in animal food products (chicken muscle, pettitoes, pig muscle, and pig liver), we established a
rapid direct competitive enzyme-linked immunosorbent assay (ELISA) using a polyclonal antibody generated from ractopamine-
linker-BSA. The antibody showed high sensitivity and speciﬁcity in phosphate buﬀe r ,w i t ha nI C 50 of 0.6ng/mL, and the limit
of detection was 0.04ng/mL. The matrix eﬀect of the samples was easily eliminated by one-step extraction with PBS, without
any organic solution or clean-up procedure such as SPE or liquid-liquid extraction, making it a much more simple and rapid
method than previously reported ones. The detection limit in blank samples was 0.2μg/kg. To validate this new RAC (ractopamine
hydrochloride) ELISA, a RAC-free pig liver sample spiked at three diﬀerent concentrations was prepared and analyzed by HPLC
and ELISA. The results showed a good correlation between the data of ELISA and HPLC (R2 > 0.95), which proves that the
established ELISA is accurate enough to quantify the residue of RAC in the animal derived foods.
Copyright © 2009 Yan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Ractopamine hydrochloride (RAC·HCl, MW 337.85,
(1R∗,3R∗),(1R∗,3S∗)-4-hydroxy-R-[[[3-(4-hydroxyphenyl)-
1-methylpropyl]amino]methyl]-benzenemethanol hydro-
chloride (Figure 1)) is a phenethanolamine member of
the family of β-adrenergic agonists (β-agonists). These
compounds are mainly used in human and veterinary
medicine as tocolytic and bronchodilator agents [1]. They
are also widely used as growth promoters in livestock
production. The advantages of feeding animals with β-
agonists have been reported to include the promotion of
repartitioning of fat into muscles, in addition to the ability
of increasing average daily weight gain, improving feed
eﬃciency, saving on feed, and decreasing the number of
days to market when higher doses are administered [2–5].
Furthermore, as a result of better feed utilization eﬃciency,
there are positive environmental beneﬁts for livestock
producers in terms of decreased nitrogen and phosphorus
excretions, and reduced amount of total animal waste [6].
However, meat products obtained from illegally treated
animals with these compounds may pose potential risks
linked to adverse cardiovascular and central nervous system
eﬀects [1].
Ractopamine, a veterinary additive drug, was approved
by the US Food and Drug Administration for the use in
swine production [7]. Recently, it has become more and
more popular not only in pig but also in chicken and cattle
production, following clenbuterol which had been the most
widely used β-agonists in livestock production. Due to its
potential risks for human health, ractopamine is still used in
arestrictedmannerwithinalowlimitofdosagewhenusedin
livestockproduction,inmanycountries.Therefore,therehas
been an increasing number of analytical methods reported
to monitor ractopamine in animal urine, feeds, and tissues
such as instrument methods like HPLC with electrochemical
detection [8] and ﬂuorescence [9], LC-MS [10, 11], and
GC-MS [12]. However, these analytical approaches, which
use several clean-up procedures (liquid-liquid extraction
(LLE) and solid-phase extraction (SPE) using diﬀerent2 Journal of Biomedicine and Biotechnology
sorbents), are quite complicated, time-consuming, and
expensive. Furthermore, integral production chain systems
currently demand faster onsite (farmhouses) and/or online
(slaughterhouses) test systems. Immunoassays as a screening
detection method can rapidly detect low amounts of residues
in many samples. Shelver et al. generated both polyclonal
[13]and monoclonal [14]antibodies toanalyzeractopamine
by ELISA. Wang et al. [15] also reported a monoclonal
antibody immunoassay to determine ractopamine in swine
feeds with a detection limit of 0.24μg/g sample. However,
all of these ELISA methods were mainly used for animal
urine or feed samples, and complicated sample clean-up
procedures(LLEandSPE)wererequiredwhenanimaltissues
were analyzed. Therefore, these tissue- (except for urine)
extraction methods combined with RAC-ELISA are too
complex as routine test systems. Moreover, to the best of
our knowledge, there is no report on the determination of
ractopamine in chicken muscle. As a result, it is necessary
to develop a more rapid, sensitive, and eﬀective method for
the determination of RAC residues in edible animal foods
including chicken muscle.
2.MaterialsandMethods
2.1. Materials
2.1.1. Chemicals and Materials. Bovine serum albumin
(BSA) was obtained from Merck (Darmstadt, Germany).
Horseradish peroxidase (HRP), ovalbumin (OVA), β-
Glucuronidase from Escherichia coli, and Freund’s complete
and incomplete adjutants were purchased from Sigma
Chemical Co. (Saint Louis, Mo, USA). Reagent grade 3,
3 ,5 ,5  -tetramethyl-benzidine (TMB), hydrogen peroxide,
isobutyl chloroformate, butane-1, 4-diol diglycidyl ether,
and other chemicals were also from Sigma. Ractopamine
hydrochloride was purchased from Pure Chemical Analysis
Co., Ltd (Bornew, Belgium). Protein A-Sepharose 4B was
purchased from Amersham Biosciences (Uppsala, Sweden).
Polystyrene 96-well microplates were from Nunc (Rockilde,
Denmark), and the microplate washer was from Bio-
Rad (Hercules, Calif, USA). Immunoassay absorbance was
read with a Multiskan Spectrum purchased from Thermo
(Labsystems, Vantaa, Finland) in the dual-wavelength mode
(450–650nm). Centrifugation was conducted by Centrifuge
5804R (Eppendorf AG, Hamburg, Germany). Double deion-
ized water (DDW) was prepared with a Milli-Q (Millipore,
Mass, USA) water puriﬁcation system.
2.1.2. Solutions. Phosphate-buﬀered saline (1 × PBS; 38.4
mmol/L Na2HPO4·H2O, 11.5mmol/L NaH2PO4·H2O,
154mmol/L NaCl, pH 7.5), phosphate-buﬀered saline with
0.05% Tween 20 (PBST), coating buﬀer (CB, 50mmol/L
sodium carbonate buﬀer, pH 9.6), blocking buﬀer (0.5%
s k i m m e dm i l kp o w d e ri n1× PBS), and TMB substrate
solution (prepared by adding 3.3mg TMB in 250μLD M S O
to 25mL phosphate-citrate buﬀer (0.1mol/L citric acid +
0.2mol/L Na2HPO4; pH 4.3) containing 3.25μLo fa
30% H2O2 solution), and termination solution (2.5mol/L
H2SO4 in DDW) were used.
2.2. Methods
2.2.1. Preparation of the Immunogen and Enzyme Conjugate.
ThehaptenRACwascoupledtoBSAastheimmunogen,and
coupled to HRP as the enzyme tracer. The coupling agent,
butane-1, 4-diol diglycidyl ether, was used for coupling RAC
to proteins.
The conjugating procedure of immunogen RAC-BSA
was adapted from Elliott et al. [16]. In brief, 10mg BSA
was dissolved in 0.5mL DDW, and the pH was adjusted
to 10.8 using 1.0mol/L sodium hydroxide. Coupling agent
solution(50μLof22μl/Lbutane-1,4-dioldiglycidyletherin
DDW) was added to the BSA solution, and the mixture was
incubated for 22 hours at room temperature under nitrogen
atmosphere.
RAC·HCl (17mg, 50μmol) was added to 0.5mL NaOH
(0.5mol/L) containing 10% dimethylformamide. The mix-
ture was then added to the epoxy-activated BSA solution
(precooled at 4◦C, in the refrigerator), slowly in an ice bath,
and incubated for 22 hours at room temperature under
nitrogen atmosphere.
TheconjugatingmethodofRAC-HRPwassimilartothat
of the immunogen in the ﬁrst step except for the amounts of
the reagents which were 5mg enzyme HRP instead of 10mg,
and 8.5mg RAC·HCl (25μmol) were added to the activated
HRP solution. Finally, the mixture was incubated for 40
hours at room temperature under a nitrogen atmosphere.
Boththeconjugatedimmunogenandenzymetracerwere
dialyzed against PBS for 3 days at 4◦C. The conjugated
immunogen was stored at −20◦C, and the enzyme tracer was
stored at 4◦C with 0.01% thiomersal until required.
2.2.2. Preparation of the Coating Conjugate. The protein
OVA was used for the preparation of the coating conjugate.
The hapten RAC was coupled to the protein OVA using
the method of mixed acid anhydride, as follows. RAC·HCl
(17mg, 50μmol) and 5mg (50μmol) succinic anhydride
were diluted in 1mL dry pyridine. After slow stirring for
24 hours at room temperature, the mixture was blown
dry with a nitrogen ﬂow. The residue was diluted in a
2mL mixture of DMF and 1, 4-dioxane (1 : 1), and
then stirred for 10 minutes in an ice bath by adding 13μL
(about 0.05mmol) tributylamine. After 7.2μL (0.05mmol)
isobutyl chloroformate were added, the mixture was stirred
for 1 hour at room temperature. Subsequently, the activated
RAC mixture was dripped onto the precooled protein OA
solution which was previously prepared with the following
method [14]. OA (10mg) was diluted in 2.5mL phosphate
buﬀer (0.1mol/L). In order to avoid protein denaturation,
dripping and stirring should be carried out at the same
time at a low temperature, and should be ﬁnished within 30
minutes. The ﬁnal mixture was stirred gently for 24 hours
at room temperature, and puriﬁed using extensive dialysis
against PBS buﬀer for 3 days at 4◦C. The puriﬁed coating
conjugate solution was stored at −20◦C with 0.02% NaN3
until required.
2.2.3. Antibody Production. Antibodies were produced in
rabbits using an immunization approach similar to thatJournal of Biomedicine and Biotechnology 3
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Figure 1: Structures of ractopamine and some closely related compounds.
described by Wang et al. [17]. Two white rabbits were
immunized by intradermal and intramuscular injections
of the emulsiﬁed RAC-BSA immunogen. After 3 initial
injections at 2-week intervals, booster injections were given
monthly. Blood was collected from the marginal ear vein 10
days after each booster injection for antibody titer assay, and
the whole blood was then collected after 6 immunizations.
The anti-RAC antiserum was centrifuged at 2000rpm
for 10 minutes (Eppendorf 5804R, Hamburg, Germany) and
stored in small tubes (about 2mL per tube) at −20◦C. The
titer for the speciﬁc antiserum was monitored by an indirect
competitive ELISA using the immunized hapten conjugated
to OVA. IgG from the antiserum was puriﬁed by Protein
A-Sepharose 4B aﬃnity chromatography. After dialyzing
against PBS buﬀer for 3 days, the puriﬁed antibodies were
stored at 4◦C with 0.02% NaN3 until required.
2.2.4. Immunoassay Procedure
(a) Indirect Competitive ELISA. Flat-bottom polystyrene
m i c r o p l a t e sw e r ec o a t e dw i t hR A C - O Ac o n j u g a t e sa t1 μg
per well in 100μL coating buﬀer, and incubated overnight
at room temperature. Plates were washed 3 times with PBST
using a 96PW microplate washer, and unbound active sites
wereblockedwith200μL0.5%skimmedmilkpowderinPBS
perwellfor1houratroomtemperature.Aftertheplateswere
washed3times,50μLoftheappropriateantiserum/antibody
dilution in PBS (the other 50μL of RAC standards in PBS
were added to determine antibody speciﬁcity) were added
in each well for titer determination, and incubated for 1
hour at room temperature. After 4 additional washes, the
plates were incubated for 1 hour at room temperature with
100μLperoxidase-labeledgoatanti-rabbitimmunoglobulins
diluted 1 : 10000 in PBS, in each well. After washing
5 times with PBST, 150μLT M Bs u b s t r a t es o l u t i o nw e r e
added to each well to measure the HRP tracer activity. The
color production of the enzymatic reaction was terminated
after 30 minutes at room temperature by adding 50μL
H2SO4 (2.5mol/L) per well. The absorbance in each well was
measuredwithaMultiskanSpectruminthedual-wavelength
mode (450nm for the test, and the whole plate background
is subtracted with the measurement at 650nm).
(b) Direct Competitive ELISA. The microplate well was
coated with puriﬁed antibodies in 100μL coating buﬀer, and
incubated overnight at room temperature. The coated plates4 Journal of Biomedicine and Biotechnology
were washed 3 times with PBST, and unbound active sites
wereblockedwith200μL0.5%skimmedmilkpowderinPBS
for 1 hour at room temperature. After the plate was washed
4t i m e s ,5 0μL of the standard solution of RAC dissolved in
PBS (or diluted sample extracts) followed by 50μLo fH R P -
hapten conjugate solution diluted in PBS were added to each
well, and the mixture was incubated in a shaker for 1 hour at
room temperature. After washing 5 times with PBST, 150μL
ofTMBsubstratesolutionwereaddedtoeachwell.Thecolor
development of the enzymatic reaction was terminated after
30 minutes at room temperature by adding 50μLH 2SO4
(2.5mol/L) per well. The absorbance was measured with a
Multiskan Spectrum in the dual-wavelength mode (450nm
for the test, and the whole plate background is subtracted
with the measurement at 650nm).
(c) Optimization of the RAC ELISA Test. Direct competitive
ELISA was used to analyze the parameters of the described
method such as the amount of the antibody coating, and
the ionic strength and pH of the diluting buﬀer. Three
diﬀerent amounts of antibodies (0.5μg, 1.0μg, and 1.5μg
antibody per well) were tested. After the optimal antibody
coating quantity was decided, the proper ionic strength was
investigated by changing the concentration of PBS buﬀer
ranging from 10 to 40mmol/L. Then, under the optimal
conditions, the eﬀects of diﬀerent pHs (pH = 6.0, 7.5, 8.5,
9.5) were tested.
(d) Sample Preparation. Four diﬀerent samples including
chicken muscle, pig muscle, pig liver, and pettitoes were
chosen to evaluate the performance of ELISA. The samples
were bought from the local markets. For the spiking study,
each sample was spiked by dropping with the RAC stan-
dard solution in methanol, making the samples with well-
distributed diﬀerent levels of RAC, the samples were thor-
oughly mixed and then allowed to stand at 4◦C overnight.
Allthesampleswerepreparedfortheimmunoassayusingthe
same extraction procedure as that for pig muscle as follows.
The sample (2g) was chopped, and mixed with 10mL PBS
for 2 minutes using a Waring blender (Omni international,
Marietta, Ga, USA). Then, the mixture was centrifuged for
10 minutes at 4,000rpmCentrifuge 5804R, Eppendorf AG,
Hamburg, Germany) at room temperature. The fat layer
was then discarded, and the upper liquid was transferred
into a test tube, and analyzed directly by direct competitive
ELISA.
2.2.5. Validation Study of ELISA by HPLC
(a) Instrumentation for HPLC Analysis. The ELISA results
were veriﬁed using an HPLC system (Shimadzu, Kyoto,
Japan) equipped with a LC-20AB pump and a RF-10Axl
FLD (excitation wavelength, 226nm; emission wavelength,
305nm). A Thermo ODS-2 HYPERSIL column (5μm,
4.6mm × 250mm) was used with a mobile phase consisting
of 0.087% 1-pentanesulfonic acid sodium salt in 2% glacial
acetic acid solution/acetonitrile (68 : 32) at a ﬂow rate
of 1.0mL/min. The injection volumes were 20μL, and the
separation was performed at 20–25◦C.
(b) Sample Pretreatment. Homogenized tissue sample (5g)
was extracted with acetonitrile (2 × 10mL) and stirred for
20 minutes on a shaker (IKA, Staufen, Germany). After
centrifugation (1,500g, 4◦C, 10 minutes), the supernatant
was transferred into a separating funnel. The acetonitrile
solution was defatted by washing with 20mL hexane (sat-
urated by acetonitrile) 3 times. Finally, 20mL of saturated
NaCl solution were added to eliminate emulsion formation.
The acetonitrile was evaporated to dryness under reduced
pressure at 50◦C. The residue was redissolved in 5mL
2% acetic acid solution, and was used for the solid-phase
extraction.
(c) Sample Clean-Up. Solid-phase extraction was carried
out using the extraction cartridges packed with multiwalled
carbon nanotubes under reduced pressure. The cartridges
were activated with 5mL methanol, followed by 5mL DDW,
and then equilibrated with 5mL 2% acetic acid solution.
After the sample extracts were loaded, the cartridges were
washed with 5mL 2% acetic acid solution, and sequentially
eluted with 7mL 5% ammonia in methanol. The eluted
sample was dried, and redissolved in 1mL 2% acetic acid for
HPLC analysis, or redissolved in appropriate volume of PBS
for ELISA analysis.
2.2.6. Deconjugation of RAC Glucuronide Metabolites. The
real food sample oﬀered by Tianjin Entry-Exit Inspection
and Quarantine Bureau was extracted by PBS according
to “Sample Preparation,” the extracts were divided into
two aliquots, one is analysed by ELISA directly and the
other is adjusted to pH 6.8 and incubated at 37◦Cf o r1 0
minutes, then dropped with β-D-glucuronidase solution,
deconjugated by for 60 minutes, the mixture was adjusted to
pH 7.5 and analysed by ELISA.
3. Results and Discussion
3.1. Optimization of RACELISA. Indirect competitive ELISA
was used to screen the antiserum. After the puriﬁcation
of the antibody and the preparation of the enzyme tracer,
direct competitive ELISA was optimized. Several parameters
including antibody coating quantity, ionic strength, and pH
of the diluting buﬀer were studied in details.
The optimal quantities of the coating antibody and
the enzyme conjugate required for the direct competitive
ELISAweredeterminedbycheckerboardtitration.Theywere
chosenaccordingtothelowestIC50 withanabsorbancevalue
of 0.7–1.2 for the control sample during color development.
The results showed that an antibody coating quantity of
1.0μg per well (100μL), and an enzyme conjugate dilution
factor of 30000 were the best among all testing conditions.
The eﬀect of ionic strength is shown in Figure 2.T h e
absorbance decreased, and the IC50 increased with an
increasing salt concentration. It is reasonable to believe that
the increased ionic strength has a detrimental eﬀect onJournal of Biomedicine and Biotechnology 5
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Figure 2: Optimization of ionic strength of the diluting buﬀer (n =
3).
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Figure 3: Optimization of pH of the diluting buﬀer (n = 3).
the interaction between the antibody and the analyte or
enzyme conjugate where ionic driving forces prevail. The
crystallizability of the buﬀer at a high salt concentration
resulted in the choice of a concentration of 10mmol/L PBS
as the optimal dilution buﬀer.
The eﬀect of the buﬀer pH is shown in Figure 3.W e
found that the IC50 reached its minimum value at pH
7.5, that is, the immunoassay for RAC was more sensitive
at pH 7.5 than at other pHs. This is because acidic and
alkaline solutions likely promote the denaturation of the
antibody and/or enzyme conjugate, causing changes in
their spatial structures with adverse eﬀects on the reactions
between the antibody and the analyte or enzyme conjugate.
Consequently, pH 7.5 was selected for further studies.
From all these results, a 10mmol/L PBS buﬀer of pH
7.5 was chosen as the optimal solvent for the RAC standard
(or samples) and enzyme conjugate dilutions, and 1.0μg
of antibody per well was the optimal coating amount. The
standard curve of RAC is shown in Figure 4. A 6-point
(stepwise dilution of the RAC standard solution) calibration
curve was performed in the ELISA test, resulting in an
average IC50 of 0.6ng/mL and average IC15 of 0.04ng/mL.
These results showed that the obtained RAC antibody was
much more sensitive than those reported by previous studies
[13, 15].
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Figure 4: Standard curve of ractopamine in PBS buﬀer (n = 6).
3.2. Analytical Characteristics of RAC ELISA
3.2.1. Speciﬁcity of the RAC Antibody. Crossreactions can
aﬀect analytical results by either giving false positives
or by elevating the predicted concentration of the tar-
get compound when both the target and one or more
structurally similar compounds are present. Therefore, the
speciﬁcity of the antibody toward a compound and its
most probable crossreactants should be determined. The
crossreactivity proﬁle of the RAC antibody was determined
by comparing the dose-response curves of RAC with those of
7 analogues including ractopamine, clenbuterol, salbutamol,
isoproterenol, terbutaline, dobutamine, and isoxsuprine
(Figure 1). All these compounds showed no cross-reactivity
with the RAC antibody except for dobutamine. Wicker et
al. [18] reported that if the antibody is developed against
a compound with a very similar structure, crossreactivity
will likely occur. In conclusion, it was reasonable that
dobutamine which has a very similar structure to RAC
showed 7.5% crossreactivity with RAC.
3.2.2. Precision of the ELISA Assay. The assay precision
was studied by determining intra-assay and inter-assay
reproducibilities. Results were obtained from 9 replicate
experiments. The variations in percent inhibition in the
intra-assay for 20, 5, 1.25, 0.31, 0.08, and 0.02ng/mL RAC
tested in a microplate were 0.5, 1.5, 4.6, 7.6, 16.1, and 29.6%,
respectively. The inter-assay of the same material run over 6
monthsresultedindeviationsfromthemeansof2.4,4.7,7.6,
10.1, 24.8, and 32.4%, respectively. The deviation became
higher with decreasing concentration. It seemed likely that
antibody sensitivity to these low concentrations was poor
and so reproducibility was greatly reduced.
3.2.3. Stabilizations of the RAC Antibody and the Enzyme
Conjugate. A rapid and reliable test is needed under extreme
ambienttemperature.Appropriate assaysinacceleratedtrials
such as the use of half-lives greater than 7 days at 37◦C
are predictive of 6–12 months stability at 4◦C. Therefore,
stability trials were carried out with RAC antibodies stored
at 4◦C, room temperature, and 37◦C for 30 days. Similar
studies were also performed with the peroxidase conjugates
f o r7d a y s .T a b l e s1 and 2 show the results of the stability6 Journal of Biomedicine and Biotechnology
assaysfortheantibodiesandenzymeconjugates,respectively.
There was not a striking change in the IC50 value of the RAC
antibody stored at diﬀerent temperatures for 30 days, and
none for the enzyme conjugates stored for 7 days. Moreover,
color loss was not observed for both rapid assays during
the experimental period. This indicated that temperature
could not easily aﬀect the activities of the RAC antibody and
enzyme conjugate. Therefore, it is reasonable to conclude
that both the antibody and enzyme tracer are stable enough
to be used in subsequent tests, and even to produce a RAC-
ELISA test kit.
3.3. Matrix Eﬀect and Their Removal. Immunoassays are
a rapid and convenient analysis method for food samples
as they usually do not require sample preconcentration
and clean-up steps. However, ELISA methods may have
high potential risks for nonspeciﬁc binding between the
nontarget analytes and antibodies, and are consequently
prone to matrix interferences. Chemical compounds present
in samples or sample extracts such as proteins, fat, and
others, might nonspeciﬁcally aﬀect the binding of the
antibody and analytes, and might also aﬀect other aspects
of the assay. These so-called “matrix eﬀects” can reduce the
sensitivity and reliability of the competitive immunoassay.
Matrix eﬀects are more pronounced in direct immunoas-
says where not only the speciﬁc antibodies but also the
enzyme conjugate are under the inﬂuence of the sample
matrix. Several methods can be used to determine matrix
eﬀects. Typically, interferences are quantiﬁed by comparing
a standard curve prepared in buﬀer such as PBS with a
calibration curve generated in the sample matrix known to
be free of the analyte. If the 2 curves are superposable, the
eﬀect of the matrix is not signiﬁcant, and the samples can
be analyzed using the standard curve prepared in the matrix-
free solution.
In the present assay, the matrix eﬀects of our samples
were analyzed using direct competitive ELISA. RAC standard
curves were prepared in PBS buﬀer, and in dilutions of
extracts of RAC-free samples to determine whether nonspe-
ciﬁc interferences could be eliminated. In order to obtain
a rapid, simple, and eﬀective sample extraction method,
several extraction solvents including methanol, ethanol,
acetonitrile, and PBS buﬀer were tested.
Signiﬁcant matrix interference was found when the
sample organic solvent extracts were diluted 5 folds in
PBS buﬀer. Further dilution of the sample organic solvent
extracts in PBS buﬀer could not reduce matrix interference.
Even the addition of ﬁsh skin gelatin (FG), skimmed
milk powder, and Tween-20 to the organic solvent extracts
could not reduce the nonspeciﬁc interactions, and lowered
the amount of developed color in the assay. When PBS
buﬀer was used as the extraction solvent alone without
any organic solvent or enshrouding reagent, the extracts
were used without any further dilution and could be
analyzed directly. The standard curves prepared in RAC-
free sample extract and in PBS buﬀer alone were super-
posable, and the matrix interference problem was easily
resolved.
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Figure 5: Standard curves of ractopamine in PBS buﬀer and in 4
sample extracts (n = 3).
The calibration curves were created by direct competitive
ELISAusingblanksamplesspikedwith6diﬀerentconcentra-
tions of RAC. Figure 5 shows the comparison of the standard
curves of RAC in extracts prepared in the 4 RAC-free samples
and in PBS buﬀer alone. Considering the dilutions of the
sample extracts, the detection limit of the assay in the blank
sampleswas0.2μg/kgwhichwasmuchlowerthanthatofthe
maximum residue levels (MRLs) for RAC in these matrices.
Thus, the loss in assay sensitivity was acceptable.
3.4. Recovery Study. To investigate the eﬃciency of the
extraction method, 4 types of edible food samples were
fortiﬁed with RAC at 3 diﬀerent levels, and were analyzed
by the established direct competitive ELISA method. Each
sample was evaluated at least 3 times to verify repeatability.
The results are shown in Table 3. It was found that all the
recoveries of the RAC residues in these samples were less
than 100%, and those in pig liver samples were little lower
than those in other samples. Since the presence of water in
these samples makes the amount of the whole extract bigger
than that of PBS that had been added prior to extraction,
the ﬁnal concentration of RAC is lower than that in theory.
Therefore, it is reasonable to conclude that pig liver with a
higher quantity of water shows a lower recovery than those
of other samples.
3.5. Correlation Studies between ELISA and HPLC Analysis.
Due to its more complicated chemical component structure,
pig liver was chosen as the representative sample in the
validation studies. Pig liver samples were spiked with RAC
at 0, 1, 2, 5μg/kg, respectively. After sample extraction and
clean-up on a solid-phase extraction column, the puriﬁed
extract was analyzed by HPLC and ELISA. The analytical
results obtained with the two methods for the same extract
were shown in Figure 6. Good correlations were obtained for
the samples (R2 = 0.9677).
Also, the spiked pig liver was analyzed by the established
ELISA with a simple extraction procedure. Figure 7 showsJournal of Biomedicine and Biotechnology 7
Table 1: Stability of the RAC-antibody.
Storage days IC50 ± SD (ng mL−1, n = 3) IC15 ± SD (ng mL−1, n = 3)
4◦CR o o m t e m p e r a t u r e 3 7 ◦C4 ◦CR o o m t e m p e r a t u r e 3 7 ◦C
10 .62 ±0.034 0.72 ±0.046 0.75 ±0.053 0.07 ±0.004 0.09 ±0.006 0.08 ±0.004
30 .48 ±0.033 0.55 ±0.036 0.61 ±0.068 0.05 ±0.005 0.06 ±0.005 0.06 ±0.005
50 .74 ±0.035 0.69 ±0.041 0.77 ±0.051 0.08 ±0.006 0.07 ±0.006 0.07 ±0.005
70 .53 ±0.038 0.56 ±0.047 0.65 ±0.063 0.05 ±0.004 0.08 ±0.007 0.09 ±0.006
30 0.53 ±0.045 0.64 ±0.063 0.61 ±0.052 0.06 ±0.007 0.07 ±0.007 0.07 ±0.006
Table 2: Stability of the enzyme tracer.
Storage days IC50 ± SD (ng mL−1, n = 3) IC15 ± SD (ng mL−1, n = 3)
4◦CR o o m t e m p e r a t u r e 3 7 ◦C4 ◦CR o o m t e m p e r a t u r e 3 7 ◦C
10 .61 ±0.035 0.54 ±0.039 0.53 ±0.042 0.06 ±0.004 0.05 ±0.005 0.05 ±0.005
30 .42 ±0.037 0.47 ±0.035 0.44 ±0.044 0.04 ±0.005 0.04 ±0.006 0.04 ±0.005
50 .61 ±0.036 0.58 ±0.032 0.83 ±0.046 0.06 ±0.004 0.07 ±0.004 0.08 ±0.006
70 .66 ±0.038 0.53 ±0.041 0.90 ±0.052 0.07 ±0.005 0.06 ±0.006 0.10 ±0.007
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Figure 6:CorrelationbetweenELISAandHPLCresultsforpuriﬁed
pig liver spiked with ractopamine at three levels (y = 1.097x +
0.1978, R2 = 0.9677, n = 9).
0
1
2
3
4
5
6
H
P
L
C
(
μ
g
k
g
−
1
)
012345
ELISA (μgk g −1)
Figure 7: Correlation between ELISA and HPLC results for non-
puriﬁed pig liver spiked with ractopamine at three levels (y =
1.1125x +0.1669, R2 = 0.9517, n = 9).
the correlations between the results of HPLC with more
complicated extraction and clean-up procedures and ELISA
with a simple extraction procedure. Despite the fact that
in this case the comparison was established with samples
subjected to diﬀerent treatments, the results correlated well
(R2 = 0.9517). These results indicate that the developed
ELISA method can be used as a rapid screening method for
the analysis of RAC in food samples.
3.6. Application in the Analysis of Real Food Samples
3.6.1. Deconjugation of RAC Glucuronide Metabolites. Rac-
topamine is converted to glucuronide metabolites by the
animal to which it is administered. So, it is important to
detect the RAC metabolites for a newly established ELISA.
Due to the lack of RAC glucuronide metabolites, they were
not involved in the cross-reactivity proﬁle of the antibody.
Before the analysis of the real food samples, β-glucuronidase
was used to deconjugate the RAC glucuronide metabolites
and prove indirectly if the antibody has the adequate binding
of glucuronide metabolites.
Real food samples with precise RAC concentration
(validatedbyHPLC-MSaccordingtoChinanationalanalysis
standard method, GBT 22147-2008) were oﬀered by Tianjin
Entry-Exit Inspection and Quarantine Bureau (export and
import samples, including pig muscle, pig liver, pettitoes).
The results showed that there is no obvious diﬀerence in the
RAC concentration of the sample extracts with and without
enzymatic hydrolysis, so we believe that the produced RAC
antibody has the ability of adequate binding with the RAC
glucuronide metabolites. Theoretically speaking, PBS should
be an appropriate extraction solution for both RAC and
the glucuronide metabolites due to the solubility of them
in PBS. So, RAC glucuronide metabolites can be analysed
by the established ELISA system without deconjugation by
glucuronidase.
3.6.2. Analysis of Real Food Samples. The real food samples
were analysed by the established rapid ELISA system. The
results were compared with the validated results (shown in
Table 4).
In analysis of the 20 food samples using the direct
competitive ELISA resulted in 15 samples being negative8 Journal of Biomedicine and Biotechnology
Table 3: Recovery studies of 4 samples at 3 levels by ELISA.
Samples Fortiﬁcation level Results (n = 3)
(μg/kg) Mean ± S.D. (μg/kg−1)R e c o v e r y ( % )C V ( % )
Chicken muscle
0.5 0.37 ±0.03 73.33 8.33
2.0 1.41 ±0.14 70.33 9.68
8.0 6.43 ±0.06 80.42 0.89
Pig muscle
0.5 0.38 ±0.04 76.73 10.23
2.0 1.41 ±0.11 70.60 7.66
8.0 5.7 ±0.26 71.25 4.64
Pig liver
1.0 0.68 ±0.06 67.67 9.50
2.0 1.33 ±0.15 66.67 11.36
5.0 3.07 ±0.20 61.33 6.59
Pettitoes
0.5 0.41 ±0.03 81.33 8.19
2.0 1.55 ±0.08 77.33 5.22
8.0 6.13 ±0.45 76.67 7.42
Table 4: Analysis results of real food samples obtained by ELISA
and comparison with validated results.
Sample ELISA resultsa
(μg/kg) (n = 3)
Validated
resultsb (μg/kg)
Pig muscle
1 ——
2 ——
3 ——
4 ——
5 ——
6
7 1.8 ±0.13 2.3
Pig liver
1 ——
2 ——
3 ——
4 2.3 ±0.11 3.3
5 3.4 ±0.12 3.7
6 5.2 ±0.18 6.1
7 3.5 ±0.19 4.2
1 ——
2 ——
Pettitoes 3 ——
4 ——
5 ——
6 ——
a , —, RAC concentration was less than LOD of the assay (0.2μg/kg);
b, Validated results was oﬀered by Tianjin Entry-Exit Inspection and
Quarantine Bureau; —, RAC concentration was less than LOD of the assay
(1.0μg/kg).
(RAC concentration was less than LOD of the assay).
Although the results obtained by ELISA was lower than
the validated results, they correlated well (R2 = 0.9605),
indicating the precision of the ELISA analytical system
and the availability of it for the analysis of real food
samples.
4. Conclusions
The developed ELISA method with a high sensitivity and
speciﬁcity is suitable for the routine screening detection
of ractopamine residues in chicken muscle, pettitoes, pig
muscle, and liver. The sample extraction method is quite
simple and rapid. Although the recoveries are not very high,
the detection limits (0.2μg/kg) from the direct competitive
ELISA for these samples are low enough for the levels of
MRL (10μg/kg for muscle, 90μg/kg for liver in Japan). The
stabilities of the RAC antibody and RAC enzyme tracer
together with the good correlation (R2 = 0.9517) between
the analytical results of HPLC and ELISA demonstrate the
accuracy of the developed ELISA procedure, conﬁrming its
reliability for applications in the rapid screening of RAC in
food samples.
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